Virbac: FY earnings up 8%

(CercleFinance.com) - The animal health group Virbac has reported a 7.
8% increase in net income (group share) to 122 million euros for 2022, and a 7.7% increase in underlying operating income before amortisation of assets acquired through acquisitions (adjusted operating income) to 186.6 million euros.

The corresponding margin therefore edged up (16.4% versus 16.3% in 2021) at constant exchange rates, for annual revenues of nearly 1.22 billion euro, up 14.3% (+9.6% excluding favourable FX impact).

For 2023, Virbac anticipates an adjusted operating margin before non-recurring items of between 13% and 14% at constant exchange rates, with currently estimated LFL sales growth of 4% to 6%.

In addition, a proposal will be made to the next general shareholder meeting to distribute a net dividend of E1.32 per share for FY 2022, up from E1.25 in 2021.


Copyright (c) 2023 CercleFinance.com. All rights reserved.